Andreassen O A, Jørgensen H A
Department of Physiology, University of Bergen, Norway.
Psychopharmacology (Berl). 1995 Jun;119(4):474-6. doi: 10.1007/BF02245864.
Rats were chronically treated for 4 weeks with three doses (4, 8, 12 mg/kg per day) of the mitochondrial toxin 3-nitropropionic acid (3-NP). The behaviour was videotaped at intervals during and after treatment, and vacuous chewing movements (VCM), a putative analogue to tardive dyskinesia (TD), as well as the general behaviour were scored. During treatment, 3-NP dose-dependently increased VCM and dose-dependently reduced motor activity, which is similar to the behavioural effect of long-term neuroleptic treatment. The results may support the hypothesis that neuroleptic-induced impairment of energy metabolism, a potential excitotoxic mechanism, is involved in the development of VCM in rats and probably TD in humans.
用三种剂量(每天4、8、12毫克/千克)的线粒体毒素3-硝基丙酸(3-NP)对大鼠进行为期4周的长期治疗。在治疗期间和治疗后,定期对大鼠行为进行录像,并对口面部不自主运动(VCM)(一种迟发性运动障碍(TD)的假定类似物)以及一般行为进行评分。在治疗期间,3-NP剂量依赖性地增加VCM,并剂量依赖性地降低运动活性,这与长期使用抗精神病药物治疗的行为效应相似。这些结果可能支持以下假说:抗精神病药物引起的能量代谢损害(一种潜在的兴奋性毒性机制)参与了大鼠VCM的发生发展,可能也参与了人类TD的发生发展。